_id
69105976ccc777a4e85d574d
Ticker
DBVT
Name
DBV Technologies
Exchange
NASDAQ
Address
BAtiment IRO, Châtillon, France, 92320
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.dbv-technologies.com
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. The company's product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. Its earlier stage research programs include vaccine for the respiratory syncytial virus, potential treatments for inflammatory bowel disease, celiac disease, and type I diabetes. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.
Last Close
19.31
Volume
387263
Current Price
16.99
Change
-0.04
Last Updated
2026-01-02T12:26:34.799Z
Image
data:image/webp;base64,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
Ipo Date
2014-10-22T00:00:00.000Z
Market Cap
769360640
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.42040000000000005
Sentiment Sources
10
Rating
3.3333
Target Price
39.9346
Strong Buy
0
Buy
2
Hold
0
Sell
1
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
4281868
Gross Profit
-4281868
Operating Expenses
32605318
Operating Income
-36887187
Interest Expense
-
Pretax Income
-35778142
Net Income
-33016481
Eps
-1.7160070050900986
Dividends Per Share
-
Shares Outstanding
40133574
Income Tax Expense
-2761660
EBITDA
-31497269
Operating Margin
-
Total Other Income Expense Net
1109044
Cash
69837000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
88882000
Property Plant Equipment
16130000
Total Assets
110495000
Payables
39816000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
57641000
Equity
52854000
Bs_currency_symbol
USD
Depreciation
792000
Change In Working Capital
-4270000
Cash From Operations
-32435000
Capital Expenditures
117000
Cash From Investing
-241000
Cash From Financing
130000
Net Change In Cash
-33370000
Cf_currency_symbol
USD
PE
-
PB
6.18482256877436
ROE
-62.46732697619859
ROA
-29.880520385537807
FCF
-32552000
Fcf Percent
-
Piotroski FScore
1
Health Score
25
Deep Value Investing Score
1.5
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
1
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
4281868
Quarters > 0 > income Statement > gross Profit
-4281868
Quarters > 0 > income Statement > operating Expenses
32605318
Quarters > 0 > income Statement > operating Income
-36887187
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-35778142
Quarters > 0 > income Statement > net Income
-33016481
Quarters > 0 > income Statement > eps
-1.7160070050900986
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
19240295
Quarters > 0 > income Statement > income Tax Expense
-2761660
Quarters > 0 > income Statement > EBITDA
-31497269
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1109044
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
69837000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
88882000
Quarters > 0 > balance Sheet > property Plant Equipment
16130000
Quarters > 0 > balance Sheet > total Assets
110495000
Quarters > 0 > balance Sheet > payables
39816000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
57641000
Quarters > 0 > balance Sheet > equity
52854000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-33164000
Quarters > 0 > cash Flow > depreciation
792000
Quarters > 0 > cash Flow > change In Working Capital
-4270000
Quarters > 0 > cash Flow > cash From Operations
-32435000
Quarters > 0 > cash Flow > capital Expenditures
117000
Quarters > 0 > cash Flow > cash From Investing
-241000
Quarters > 0 > cash Flow > cash From Financing
130000
Quarters > 0 > cash Flow > net Change In Cash
-33370000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.7160070050900986
Quarters > 0 > ratios > PB
6.18482256877436
Quarters > 0 > ratios > ROE
-62.46732697619859
Quarters > 0 > ratios > ROA
-29.880520385537807
Quarters > 0 > ratios > FCF
-32552000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
25
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
4619486
Quarters > 1 > income Statement > gross Profit
-4619486
Quarters > 1 > income Statement > operating Expenses
38492008
Quarters > 1 > income Statement > operating Income
-43111495
Quarters > 1 > income Statement > interest Expense
656165
Quarters > 1 > income Statement > pretax Income
-43767660
Quarters > 1 > income Statement > net Income
-42402674
Quarters > 1 > income Statement > eps
-2.2045621472370596
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
19234057
Quarters > 1 > income Statement > income Tax Expense
-1364986
Quarters > 1 > income Statement > EBITDA
-38492008
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-656165
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
103207000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
15691000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
121241000
Quarters > 1 > balance Sheet > property Plant Equipment
16830000
Quarters > 1 > balance Sheet > total Assets
143429000
Quarters > 1 > balance Sheet > payables
40792000
Quarters > 1 > balance Sheet > short Term Debt
8889000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
57205000
Quarters > 1 > balance Sheet > equity
86224000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-41875000
Quarters > 1 > cash Flow > depreciation
760000
Quarters > 1 > cash Flow > change In Working Capital
-537000
Quarters > 1 > cash Flow > cash From Operations
-33905000
Quarters > 1 > cash Flow > capital Expenditures
32000
Quarters > 1 > cash Flow > cash From Investing
-38000
Quarters > 1 > cash Flow > cash From Financing
116947000
Quarters > 1 > cash Flow > net Change In Cash
90245000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-2.2045621472370596
Quarters > 1 > ratios > PB
3.789972959152904
Quarters > 1 > ratios > ROE
-49.17734505474114
Quarters > 1 > ratios > ROA
-29.563528993439263
Quarters > 1 > ratios > FCF
-33937000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
511000
Quarters > 2 > income Statement > cost Of Revenue
4477344
Quarters > 2 > income Statement > gross Profit
-4477344
Quarters > 2 > income Statement > operating Expenses
22914117
Quarters > 2 > income Statement > operating Income
-27391462
Quarters > 2 > income Statement > interest Expense
461000
Quarters > 2 > income Statement > pretax Income
-27852807
Quarters > 2 > income Statement > net Income
-27099244
Quarters > 2 > income Statement > eps
-1.3204071450149586
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
20523400
Quarters > 2 > income Statement > income Tax Expense
-753562
Quarters > 2 > income Statement > EBITDA
-22914117
Quarters > 2 > income Statement > operating Margin
-5360.364383561644
Quarters > 2 > income Statement > total Other Income Expense Net
-461344
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
12962000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
12311000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
29148000
Quarters > 2 > balance Sheet > property Plant Equipment
16425999
Quarters > 2 > balance Sheet > total Assets
50562000
Quarters > 2 > balance Sheet > payables
34146000
Quarters > 2 > balance Sheet > short Term Debt
5824000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
47688999
Quarters > 2 > balance Sheet > equity
2873000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-23015000
Quarters > 2 > cash Flow > depreciation
638000
Quarters > 2 > cash Flow > change In Working Capital
6000
Quarters > 2 > cash Flow > cash From Operations
-19668000
Quarters > 2 > cash Flow > capital Expenditures
10000
Quarters > 2 > cash Flow > cash From Investing
-375000
Quarters > 2 > cash Flow > cash From Financing
45000
Quarters > 2 > cash Flow > net Change In Cash
-19494000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.3204071450149586
Quarters > 2 > ratios > PB
121.36880125304559
Quarters > 2 > ratios > ROE
-943.2385659589279
Quarters > 2 > ratios > ROA
-53.59606819350501
Quarters > 2 > ratios > FCF
-19678000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-38.50880626223092
Quarters > 2 > health Score
9
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
23861000
Quarters > 3 > income Statement > operating Income
-23861000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-23008000
Quarters > 3 > income Statement > net Income
-23015000
Quarters > 3 > income Statement > eps
-1.1965754286784114
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
19234057
Quarters > 3 > income Statement > income Tax Expense
7000
Quarters > 3 > income Statement > EBITDA
-22797000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
853000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
32456000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
10391000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
44388000
Quarters > 3 > balance Sheet > property Plant Equipment
16808000
Quarters > 3 > balance Sheet > total Assets
65658000
Quarters > 3 > balance Sheet > payables
22032000
Quarters > 3 > balance Sheet > short Term Debt
1500000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
38271000
Quarters > 3 > balance Sheet > equity
27388000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-23015000
Quarters > 3 > cash Flow > depreciation
638000
Quarters > 3 > cash Flow > change In Working Capital
11250000
Quarters > 3 > cash Flow > cash From Operations
-12252000
Quarters > 3 > cash Flow > capital Expenditures
125000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
675000
Quarters > 3 > cash Flow > net Change In Cash
-13985000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.1965754286784114
Quarters > 3 > ratios > PB
11.9317448674602
Quarters > 3 > ratios > ROE
-84.03315320578355
Quarters > 3 > ratios > ROA
-35.05284961466996
Quarters > 3 > ratios > FCF
-12377000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
25
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2568000
Annuals > 0 > income Statement > cost Of Revenue
6813942
Annuals > 0 > income Statement > gross Profit
-6813942
Annuals > 0 > income Statement > operating Expenses
113712776
Annuals > 0 > income Statement > operating Income
-120526718
Annuals > 0 > income Statement > interest Expense
740000
Annuals > 0 > income Statement > pretax Income
-117800542
Annuals > 0 > income Statement > net Income
-113716769
Annuals > 0 > income Statement > eps
-5.912278725174171
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
19234000
Annuals > 0 > income Statement > income Tax Expense
-4083773
Annuals > 0 > income Statement > EBITDA
-110986601
Annuals > 0 > income Statement > operating Margin
-4693.408021806854
Annuals > 0 > income Statement > total Other Income Expense Net
2726175
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
32456000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
10391000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
44388000
Annuals > 0 > balance Sheet > property Plant Equipment
16808000
Annuals > 0 > balance Sheet > total Assets
65658000
Annuals > 0 > balance Sheet > payables
22032000
Annuals > 0 > balance Sheet > short Term Debt
1500000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
38271000
Annuals > 0 > balance Sheet > equity
27388000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-113918000
Annuals > 0 > cash Flow > depreciation
-925000
Annuals > 0 > cash Flow > change In Working Capital
5752000
Annuals > 0 > cash Flow > cash From Operations
-104474000
Annuals > 0 > cash Flow > capital Expenditures
2341000
Annuals > 0 > cash Flow > cash From Investing
-757000
Annuals > 0 > cash Flow > cash From Financing
587000
Annuals > 0 > cash Flow > net Change In Cash
-108911000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-5.912278725174171
Annuals > 0 > ratios > PB
13.46267635460786
Annuals > 0 > ratios > ROE
-415.206546662772
Annuals > 0 > ratios > ROA
-173.1956029729812
Annuals > 0 > ratios > FCF
-106815000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-41.5946261682243
Annuals > 0 > health Score
16
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
15728000
Annuals > 1 > income Statement > cost Of Revenue
-4497000
Annuals > 1 > income Statement > gross Profit
15728000
Annuals > 1 > income Statement > operating Expenses
92160000
Annuals > 1 > income Statement > operating Income
-76432000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-72719000
Annuals > 1 > income Statement > net Income
-72726000
Annuals > 1 > income Statement > eps
-3.8228151512284354
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
19024200
Annuals > 1 > income Statement > income Tax Expense
7000
Annuals > 1 > income Statement > EBITDA
-63271000
Annuals > 1 > income Statement > operating Margin
-485.9613428280773
Annuals > 1 > income Statement > total Other Income Expense Net
3713000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
141367000
Annuals > 1 > balance Sheet > short Term Investments
-13392529
Annuals > 1 > balance Sheet > receivables
15445000
Annuals > 1 > balance Sheet > inventories
-440574
Annuals > 1 > balance Sheet > total Current Assets
158915000
Annuals > 1 > balance Sheet > property Plant Equipment
17928000
Annuals > 1 > balance Sheet > total Assets
182986000
Annuals > 1 > balance Sheet > payables
23302000
Annuals > 1 > balance Sheet > short Term Debt
2027000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
42799000
Annuals > 1 > balance Sheet > equity
140186000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-72726000
Annuals > 1 > cash Flow > depreciation
-13998000
Annuals > 1 > cash Flow > change In Working Capital
953000
Annuals > 1 > cash Flow > cash From Operations
-79653000
Annuals > 1 > cash Flow > capital Expenditures
677000
Annuals > 1 > cash Flow > cash From Investing
-808000
Annuals > 1 > cash Flow > cash From Financing
6767000
Annuals > 1 > cash Flow > net Change In Cash
-67827000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-3.8228151512284354
Annuals > 1 > ratios > PB
2.6015002496682977
Annuals > 1 > ratios > ROE
-51.87821893769706
Annuals > 1 > ratios > ROA
-39.744024132993786
Annuals > 1 > ratios > FCF
-80330000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-5.107451678535097
Annuals > 1 > health Score
35
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
4800000
Annuals > 2 > income Statement > cost Of Revenue
20299000
Annuals > 2 > income Statement > gross Profit
-15499000
Annuals > 2 > income Statement > operating Expenses
101475000
Annuals > 2 > income Statement > operating Income
-96631000
Annuals > 2 > income Statement > interest Expense
427000
Annuals > 2 > income Statement > pretax Income
-96204000
Annuals > 2 > income Statement > net Income
-96300000
Annuals > 2 > income Statement > eps
-6.2222164788586785
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
15476800
Annuals > 2 > income Statement > income Tax Expense
70000
Annuals > 2 > income Statement > EBITDA
-76679000
Annuals > 2 > income Statement > operating Margin
-2013.1458333333335
Annuals > 2 > income Statement > total Other Income Expense Net
427000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
209194000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
10494260
Annuals > 2 > balance Sheet > inventories
2680000
Annuals > 2 > balance Sheet > total Current Assets
223074000
Annuals > 2 > balance Sheet > property Plant Equipment
17609000
Annuals > 2 > balance Sheet > total Assets
246518000
Annuals > 2 > balance Sheet > payables
14473000
Annuals > 2 > balance Sheet > short Term Debt
3025000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
52065000
Annuals > 2 > balance Sheet > equity
194454000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-96274000
Annuals > 2 > cash Flow > depreciation
13162000
Annuals > 2 > cash Flow > change In Working Capital
22320000
Annuals > 2 > cash Flow > cash From Operations
-55700000
Annuals > 2 > cash Flow > capital Expenditures
754000
Annuals > 2 > cash Flow > cash From Investing
-100000
Annuals > 2 > cash Flow > cash From Financing
194100000
Annuals > 2 > cash Flow > net Change In Cash
131900000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-6.2222164788586785
Annuals > 2 > ratios > PB
1.5257606220494309
Annuals > 2 > ratios > ROE
-49.52328057021198
Annuals > 2 > ratios > ROA
-39.06408456988942
Annuals > 2 > ratios > FCF
-56454000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-11.76125
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
5708000
Annuals > 3 > income Statement > cost Of Revenue
9273000
Annuals > 3 > income Statement > gross Profit
-3565000
Annuals > 3 > income Statement > operating Expenses
93931000
Annuals > 3 > income Statement > operating Income
-98614000
Annuals > 3 > income Statement > interest Expense
690000
Annuals > 3 > income Statement > pretax Income
-98190000
Annuals > 3 > income Statement > net Income
-97809000
Annuals > 3 > income Statement > eps
-8.87623420937999
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
11019200
Annuals > 3 > income Statement > income Tax Expense
-381000
Annuals > 3 > income Statement > EBITDA
-91159000
Annuals > 3 > income Statement > operating Margin
-1727.645409950946
Annuals > 3 > income Statement > total Other Income Expense Net
424000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
77301000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
33066000
Annuals > 3 > balance Sheet > inventories
-32936000
Annuals > 3 > balance Sheet > total Current Assets
114516000
Annuals > 3 > balance Sheet > property Plant Equipment
24917000
Annuals > 3 > balance Sheet > total Assets
146323000
Annuals > 3 > balance Sheet > payables
11430000
Annuals > 3 > balance Sheet > short Term Debt
3513000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
47293999
Annuals > 3 > balance Sheet > equity
99029000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-97809000
Annuals > 3 > cash Flow > depreciation
8376000
Annuals > 3 > cash Flow > change In Working Capital
-22771000
Annuals > 3 > cash Flow > cash From Operations
-108242000
Annuals > 3 > cash Flow > capital Expenditures
918000
Annuals > 3 > cash Flow > cash From Investing
-433000
Annuals > 3 > cash Flow > cash From Financing
274000
Annuals > 3 > cash Flow > net Change In Cash
-119051000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-8.87623420937999
Annuals > 3 > ratios > PB
2.133092972765554
Annuals > 3 > ratios > ROE
-98.76803764553817
Annuals > 3 > ratios > ROA
-66.84458355829227
Annuals > 3 > ratios > FCF
-109160000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-19.124036440084094
Annuals > 3 > health Score
34
Valuation > metrics > PE
-1.7160070050900986
Valuation > metrics > PB
6.18482256877436
Valuation > final Score
20
Valuation > verdict
106.2% Overvalued
Profitability > metrics > ROE
-62.46732697619859
Profitability > metrics > ROA
-37.146419972547875
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.0905702501229804
Risk > metrics > Interest Coverage
-8.616744061316465
Risk > final Score
-4
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.2323186658629695
Liquidity > metrics > Quick Ratio
2.2323186658629695
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
42.10027040847096
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
0
Prev Profitabilities > 2
15
Prev Risks > 0
-215
Prev Risks > 1
-232
Prev Risks > 2
-422
Prev Liquidities > 0
100
Prev Liquidities > 1
46
Prev Liquidities > 2
97
Updated At
2026-01-20T21:41:55.700Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-10-28
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.24
Earnings History > 0 > eps Estimate
-0.2917
Earnings History > 0 > eps Difference
0.0517
Earnings History > 0 > surprise Percent
17.7237
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-07-29
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.31
Earnings History > 1 > eps Estimate
-0.1567
Earnings History > 1 > eps Difference
-0.1533
Earnings History > 1 > surprise Percent
-97.8302
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-11
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.23
Earnings History > 2 > eps Estimate
-0.2267
Earnings History > 2 > eps Difference
-0.0033
Earnings History > 2 > surprise Percent
-1.4557
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-05
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
-0.2126
Earnings History > 3 > eps Estimate
-0.21
Earnings History > 3 > eps Difference
-0.0026
Earnings History > 3 > surprise Percent
-1.2381
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
-1.4909
Earnings History > 4 > eps Estimate
-1.6425
Earnings History > 4 > eps Difference
0.1516
Earnings History > 4 > surprise Percent
9.2298
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-07-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
-0.34
Earnings History > 5 > eps Estimate
-0.45
Earnings History > 5 > eps Difference
0.11
Earnings History > 5 > surprise Percent
24.4444
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.56
Earnings History > 6 > eps Estimate
-0.21
Earnings History > 6 > eps Difference
-0.35
Earnings History > 6 > surprise Percent
-166.6667
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-07
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.0581
Earnings History > 7 > eps Estimate
-0.23
Earnings History > 7 > eps Difference
0.1719
Earnings History > 7 > surprise Percent
74.7391
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-10-31
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.08
Earnings History > 8 > eps Estimate
-0.22
Earnings History > 8 > eps Difference
0.14
Earnings History > 8 > surprise Percent
63.6364
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-07-31
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-0.12
Earnings History > 9 > eps Estimate
-0.19
Earnings History > 9 > eps Difference
0.07
Earnings History > 9 > surprise Percent
36.8421
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-04
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.22
Earnings History > 10 > eps Estimate
-0.2067
Earnings History > 10 > eps Difference
-0.0133
Earnings History > 10 > surprise Percent
-6.4344
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-02
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-0.44
Earnings History > 11 > eps Estimate
-0.17
Earnings History > 11 > eps Difference
-0.27
Earnings History > 11 > surprise Percent
-158.8235
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-03
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-0.18
Earnings History > 12 > eps Estimate
-0.32
Earnings History > 12 > eps Difference
0.14
Earnings History > 12 > surprise Percent
43.75
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-01
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-0.33
Earnings History > 13 > eps Estimate
-0.31
Earnings History > 13 > eps Difference
-0.02
Earnings History > 13 > surprise Percent
-6.4516
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-02
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-0.27
Earnings History > 14 > eps Estimate
-0.39
Earnings History > 14 > eps Difference
0.12
Earnings History > 14 > surprise Percent
30.7692
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-03
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-0.11
Earnings History > 15 > eps Estimate
-0.49
Earnings History > 15 > eps Difference
0.38
Earnings History > 15 > surprise Percent
77.551
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-10-26
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-0.19
Earnings History > 16 > eps Estimate
-0.43
Earnings History > 16 > eps Difference
0.24
Earnings History > 16 > surprise Percent
55.814
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-02
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
-0.28
Earnings History > 17 > eps Estimate
-0.48
Earnings History > 17 > eps Difference
0.2
Earnings History > 17 > surprise Percent
41.6667
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-03
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
-0.22
Earnings History > 18 > eps Estimate
-0.51
Earnings History > 18 > eps Difference
0.29
Earnings History > 18 > surprise Percent
56.8627
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-11
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
-2.95
Earnings History > 19 > eps Estimate
-1.22
Earnings History > 19 > eps Difference
-1.73
Earnings History > 19 > surprise Percent
-141.8033
Earnings History > 20 > period
2019-12-31
Earnings History > 20 > report Date
2020-03-04
Earnings History > 20 > date
2019-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
0.6
Earnings History > 20 > eps Estimate
-1.78
Earnings History > 20 > eps Difference
2.38
Earnings History > 20 > surprise Percent
133.7079
Earnings History > 21 > period
2019-09-30
Earnings History > 21 > report Date
2019-09-30
Earnings History > 21 > date
2019-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
-0.42
Earnings History > 21 > eps Estimate
-0.47
Earnings History > 21 > eps Difference
0.05
Earnings History > 21 > surprise Percent
10.6383
Earnings History > 22 > period
2017-12-31
Earnings History > 22 > report Date
2018-03-14
Earnings History > 22 > date
2017-12-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
EUR
Earnings History > 22 > eps Actual
0
Earnings History > 22 > eps Estimate
-2.07
Earnings History > 22 > eps Difference
2.07
Earnings History > 22 > surprise Percent
100
Earnings History > 23 > period
2017-06-30
Earnings History > 23 > report Date
2017-07-28
Earnings History > 23 > date
2017-06-30
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
EUR
Earnings History > 23 > eps Actual
2.94
Earnings History > 23 > eps Estimate
-1.57
Earnings History > 23 > eps Difference
4.51
Earnings History > 23 > surprise Percent
287.2611
Earnings History > 24 > period
2017-03-31
Earnings History > 24 > report Date
2017-04-06
Earnings History > 24 > date
2017-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
EUR
Earnings History > 24 > eps Actual
0
Earnings History > 24 > eps Estimate
-1.54
Earnings History > 24 > eps Difference
1.54
Earnings History > 24 > surprise Percent
100
Earnings History > 25 > period
2016-12-31
Earnings History > 25 > report Date
2017-03-15
Earnings History > 25 > date
2016-12-31
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
EUR
Earnings History > 25 > eps Actual
-4.68
Earnings History > 25 > eps Estimate
-1.02
Earnings History > 25 > eps Difference
-3.66
Earnings History > 25 > surprise Percent
-358.8235
Earnings History > 26 > period
2016-06-30
Earnings History > 26 > report Date
2016-07-28
Earnings History > 26 > date
2016-06-30
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
EUR
Earnings History > 26 > eps Actual
-2.03
Earnings History > 26 > eps Estimate
-0.57
Earnings History > 26 > eps Difference
-1.46
Earnings History > 26 > surprise Percent
-256.1404
Earnings History > 27 > period
2016-03-31
Earnings History > 27 > report Date
2016-04-11
Earnings History > 27 > date
2016-03-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
EUR
Earnings History > 27 > eps Actual
0
Earnings History > 27 > eps Estimate
-0.56
Earnings History > 27 > eps Difference
0.56
Earnings History > 27 > surprise Percent
100
Earnings History > 28 > period
2015-06-30
Earnings History > 28 > report Date
2015-07-27
Earnings History > 28 > date
2015-06-30
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
EUR
Earnings History > 28 > eps Actual
-0.2413
Earnings History > 28 > eps Estimate
-0.58
Earnings History > 28 > eps Difference
0.3387
Earnings History > 28 > surprise Percent
58.3966
Earnings History > 29 > period
2015-03-31
Earnings History > 29 > report Date
2015-04-29
Earnings History > 29 > date
2015-03-31
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
EUR
Earnings History > 29 > eps Actual
-0.1761
Earnings History > 29 > eps Estimate
-0.56
Earnings History > 29 > eps Difference
0.3839
Earnings History > 29 > surprise Percent
68.5536
Earnings History > 30 > period
2014-12-31
Earnings History > 30 > report Date
2015-03-26
Earnings History > 30 > date
2014-12-31
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
EUR
Earnings History > 30 > eps Actual
-0.79
Earnings History > 30 > eps Estimate
-0.44
Earnings History > 30 > eps Difference
-0.35
Earnings History > 30 > surprise Percent
-79.5455
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. The company's product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. Its earlier stage research programs include vaccine for the respiratory syncytial virus, potential treatments for inflammatory bowel disease, celiac disease, and type I diabetes. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWill NETSTREIT Corp. stock reach Wall Street targets - 2025 Investor Takeaways & Community Shared Stock Ideas bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$39.9346
Analyst Picks
Strong Buy
0
Buy
2
Hold
0
Sell
1
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.01% of the total shares of DBV Technologies
1.
Fidelity Nasdaq Composite Index(0.0142%)
since
2025/07/31
2.
ST Dorsey Wright® Intl Momntm Tr 39 CA(0.0004%)
since
2025/08/29
3.
Boxer Capital Management, LLC(0%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.24
EPS Estimate
-0.2917
EPS Difference
0.0517
Surprise Percent
17.7237%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.